CLINICAL OUTCOMES AND DIAGNOSIS‐TO‐TREATMENT INTERVAL IN PATIENTS WITH NK/T‐CELL LYMPHOMA: 7‐YEAR FOLLOW‐UP OF THE NKEA STUDY. (12th June 2019)